VER-01 for Painful Diabetic Peripheral Neuropathy (PDPN)

About Vertanical

Vertanical is a clinical-stage biopharma company pioneering cannabinoid-based treatments for chronic pain. Its lead candidate, VER-01, is in late-stage development for chronic low back pain, with a marketing application submitted in Germany, and has additional planned programs for osteoarthritis and painful diabetic neuropathy. The company operates an advanced GMP manufacturing facility and runs a robust clinical program across Europe and the US, positioning itself as a potential disruptor in the global pain management market, which affects over a billion people.

Therapeutic Areas